|
SLC38A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.778600E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.701800E-03 |
| Normal-vs-Stage2 |
7.052200E-02 |
| Normal-vs-Stage3 |
1.662000E-01 |
| Normal-vs-Stage4 |
1.517810E-01 |
| Stage1-vs-Stage2 |
9.289800E-01 |
| Stage1-vs-Stage3 |
6.191200E-01 |
| Stage1-vs-Stage4 |
7.947200E-01 |
| Stage2-vs-Stage3 |
7.581600E-01 |
| Stage2-vs-Stage4 |
7.529200E-01 |
| Stage3-vs-Stage4 |
6.025200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.957900E-03 |
| Normal-vs-AfricanAmerican |
1.239020E-03 |
| Normal-vs-Asian |
1.707010E-01 |
| Caucasian-vs-AfricanAmerican |
3.170800E-01 |
| Caucasian-vs-Asian |
3.554400E-01 |
| AfricanAmerican-vs-Asian |
5.431600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.987700E-04 |
| Normal-vs-Female |
4.996100E-03 |
| Male-vs-Female |
9.548600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.200400E-02 |
| Normal-vs-Extreme_Weight |
1.031640E-01 |
| Normal-vs-Obese |
3.005100E-04 |
| Normal-vs-Extreme_Obese |
4.832600E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.342600E-01 |
| Normal_Weight-vs-Obese |
1.242570E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.594000E-01 |
| Extreme_Weight-vs-Obese |
1.889520E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.406800E-01 |
| Obese-vs-Extreme_Obese |
2.992000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.237600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.69120000000001E-05 |
| Normal-vs-Age(61-80Yrs) |
2.119500E-02 |
| Normal-vs-Age(81-100Yrs) |
7.623000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.852800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.471560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.532100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.309800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.203700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.180200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.65536999999771E-05 |
| Normal-VS-Type2 PRCC |
8.703000E-01 |
| Normal-VS-KIRP CIMP |
3.477100E-03 |
| Normal-VS-Unclassified PRCC |
2.384100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.80090000029476E-07 |
| Type1 PRCC-VS-KIRP CIMP |
7.187200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.277400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.222900E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.562280E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.056800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.964400E-01 |
| Normal-vs-N1 |
1.963960E-02 |
| Normal-vs-N2 |
8.823700E-02 |
| N0-vs-N1 |
6.685900E-02 |
| N0-vs-N2 |
4.237200E-01 |
| N1-vs-N2 |
9.024400E-01 |
|
|
